Literature DB >> 18363123

Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method.

Hakan Doneray1, Behzat Ozkan, Ibrahim Caner, Asuman Ozkan, Cahit Karakelleoglu.   

Abstract

In recent years, alendronate, an oral biphosphonate, has been added to therapy of hypercalcemia secondary to vitamin D intoxication in children. Alendronate may cause mucosal ulcerations in the mouth and esophagus. We report our experience in two infants with vitamin D intoxication to whom alendronate therapy was administered through nasogastric tube, an alternate route for alendronate administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363123     DOI: 10.1080/15563650701455361

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  3 in total

1.  Reply to the correspondence letter by Dr. Mitra S. to "alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis".

Authors:  Nilay Hakan; Mustafa Aydin; Ayşegul Zenciroglu
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

Review 2.  Benefit-risk assessment of vitamin D supplementation.

Authors:  H A Bischoff-Ferrari; A Shao; B Dawson-Hughes; J Hathcock; E Giovannucci; W C Willett
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

3.  Dihydrotachysterol intoxication treated with pamidronate: a case report.

Authors:  Mojca Jensterle; Marija Pfeifer; Matjaz Sever; Tomaz Kocjan
Journal:  Cases J       Date:  2010-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.